Journal of Medicinal Chemistry · 2010 · 37 citations · 29 references
PharmacyMedicinal ChemistryPharmacologyBiosensorsDrug DesignDrug DiscoveryLigand BindingLigand-based DesignProtein-ligand BindingProtein-ligand InteractionsProtein-ligand RecognitionReceptor-ligand InteractionsBinder IdentificationBiophysical AssaysFragment Library ScreeningFragment Screening LibrariesFragment-based Library ConstructionLigand-binding AssaysSurface Plasmon Resonance BiosensorsSurface Plasmon Resonance Screening
The soluble acetylcholine binding protein (AChBP) is a homologue of the ligand-binding domain of the nicotinic acetylcholine receptors (nAChR). To guide future fragment-screening using surface plasmon resonance (SPR) biosensor technology as a label-free, direct binding, biophysical screening assay, a focused fragment library was generated based on deconstruction of a set of α7 nAChR selective quinuclidine containing ligands with nanomolar affinities. The interaction characteristics of the fragments and the parent compounds with AChBP were evaluated using an SPR biosensor assay. The data obtained from this direct binding assay correlated well with data from the reference radioligand displacement assay. Ligand efficiencies for different (structural) groups of fragments in the library were correlated to binding with distinct regions of the binding pocket, thereby identifying ligand efficiency hot spots (LE hot spots). These hot spots can be used to identity the most promising hit fragments in a large scale fragment library screen.
29
The maximal affinity of ligands
Irwin D. Kuntz, K. Chen, Kim A. Sharp et al. · Proceedings of the National Academy of Sciences · 1999 · 845 citations
A glia-derived acetylcholine-binding protein that modulates synaptic transmission
August B. Smit, Naweed I. Syed, Dick Schaap et al. · Nature · 2001 · 567 citations
Ligand efficiency indices as guideposts for drug discovery
C ABADZAPATERO · Drug Discovery Today · 2005 · 523 citations